Author:
Ridouani Fourat,Alberto Vargas H.,Holzwanger Daniel J.,Schöder Heiko,Waters Emily,Petre Elena N.,Martin Axel,Satagopan Jaya,Gonen Mithat,Autio Karen A.,Chen Yu,Slovin Susan F.,Danila Daniel C.,Morris Michael J.,Scher Howard I.,Arcila Maria E.,Solomon Stephen B.,Durack Jeremy C.
Funder
National Institutes of Health
National Cancer Institute
Reference21 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019
2. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients;Bubendorf;Hum Pathol,2000
3. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015
4. Abida W, Armenia J, Gopalan A, et al. Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making. JCO Precis Oncol 2017;2017:PO.17.00029.
5. Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients;Zhao;Clin Transl Med,2019